ROMO1 Mouse Monoclonal Antibody [Clone ID: OTI2C12]
CAT#: CF505580
Carrier-free (BSA/glycerol-free) ROMO1 mouse monoclonal antibody, clone OTI2C12 (formerly 2C12)
Formulation: Standard
View other "OTI2C12" antibodies (4)
Need it in bulk or conjugated?
Get a free quote
CNY 3,999.00
Cited in 5 publications. |
Specifications
Product Data | |
Clone Name | OTI2C12 |
Applications | IF, IHC, WB |
Recommend Dilution | WB 1:2000, IHC 1:150, IF 1:100 |
Reactivity | Human, Mouse, Rat, Dog, Monkey |
Host | Mouse |
Clonality | Monoclonal |
Immunogen | Full length human recombinant protein of human ROMO1(NP_542786) produced in HEK293T cell. |
Formulation | Lyophilized powder (original buffer 1X PBS, pH 7.3, 8% trehalose) |
Reconstitution Method | For reconstitution, we recommend adding 100uL distilled water to a final antibody concentration of about 1 mg/mL. To use this carrier-free antibody for conjugation experiment, we strongly recommend performing another round of desalting process. (OriGene recommends Zeba Spin Desalting Columns, 7KMWCO from Thermo Scientific) |
Purification | Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G) |
Conjugation | Unconjugated |
Storage Condition | Store at -20°C as received. |
Predicted Protein Size | 8 kDa |
Gene Name | reactive oxygen species modulator 1 |
Database Link | |
Synonyms | bA353C18.2; C20orf52; MTGM; MTGMP |
Reference Data | |
Protein Families | Transmembrane |
Citations (5)
The use of this Antibodies has been cited in the following citations: |
---|
Overexpression of Reactive Oxygen Species Modulator 1 Predicts Unfavorable Clinical Outcome in EGFR-Mutant Lung Adenocarcinomas Treated With Targeted Therapy
,null,
Frontiers in Oncology
,PubMed ID 34956890
[ROMO1]
|
Reactive Oxygen Species Modulator 1 As An Adverse Prognostic Marker In Stage III Non-Small Cell Lung Cancer Treated With Radiotherapy: A Retrospective Pilot Study
,null,
OncoTargets and therapy
,PubMed ID 31632076
[ROMO1]
|
Reactive Oxygen Species Modulator 1 (Romo1) Predicts Poor Outcomes in Advanced Non-small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy
,null,
Cancer Research and Treatment : Official Journal of Korean Cancer Association
,PubMed ID 27188201
[ROMO1]
|
Romo1 and the NF-κB pathway are involved in oxidative stress-induced tumor cell invasion.
,null,
International journal of oncology
,PubMed ID 25673177
[ROMO1]
|
Reactive oxygen species modulator 1 (Romo1) overexpression is an independent predictor of poor survival in NSCLC patients who undergo surgical resection.
,null,
Lung cancer (Amsterdam, Netherlands)
,PubMed ID 25468147
[ROMO1]
|
Documents
Product Manuals |
FAQs |
SDS |
Resources
抗体相关资料 |
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
TA505580 | ROMO1 mouse monoclonal antibody, clone OTI2C12 (formerly 2C12) |
CNY 1,999.00 |
|
TA505580AM | ROMO1 mouse monoclonal antibody,clone 2C12, Biotinylated |
CNY 3,990.00 |
|
TA505580BM | ROMO1 mouse monoclonal antibody,clone 2C12, HRP conjugated |
CNY 3,990.00 |
|
TA505580S | ROMO1 mouse monoclonal antibody, clone OTI2C12 (formerly 2C12) |
CNY 800.00 |